We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$615M
AUM Growth
-$265M
Cap. Flow
-$210M
Cap. Flow %
-34.24%
Top 10 Hldgs %
73.3%
Holding
97
New
9
Increased
13
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$3.8M
2
LHX icon
L3Harris
LHX
+$2.71M
3
MCK icon
McKesson
MCK
+$2.6M
4
UNH icon
UnitedHealth
UNH
+$2.21M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.95M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$43.4M
2
UPS icon
United Parcel Service
UPS
+$25.2M
3
KO icon
Coca-Cola
KO
+$19M
4
DIS icon
Walt Disney
DIS
+$8.27M
5
PG icon
Procter & Gamble
PG
+$7.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 56.11%
2 Energy 10.64%
3 Healthcare 10.54%
4 Industrials 7.86%
5 Technology 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.59M 0.26%
14,215
-3,335
-19% -$422K
PX
52
DELISTED
Praxair Inc
PX
$1.52M 0.25%
13,170
-4,390
-25% -$575K
TEVA icon
53
Teva Pharmaceuticals
TEVA
$35.9B
$1.5M 0.24%
+38,200
New +$1.95M
CI icon
54
Cigna
CI
$76.6B
$1.42M 0.23%
19,600
+1,900
+11% +$163K
SYK icon
55
Stryker
SYK
$127B
$1.4M 0.23%
21,597
+10,397
+93% +$849K
DIS icon
56
Walt Disney
DIS
$165B
$1.37M 0.22%
21,650
-101,202
-82% -$8.27M
EBAY icon
57
eBay
EBAY
$48.6B
$1.35M 0.22%
62,014
-17,463
-22% -$380K
MO icon
58
Altria Group
MO
$122B
$1.35M 0.22%
38,577
-12,203
-24% -$491K
JCI icon
59
Johnson Controls International
JCI
$87.5B
$1.29M 0.21%
34,493
+12,160
+54% +$605K
CLX icon
60
Clorox
CLX
$11.6B
$1.27M 0.21%
+15,255
New +$1.37M
FISV
61
Fiserv Inc
FISV
$27.2B
$1.22M 0.2%
28,000
-5,560
-17% -$165K
HAS icon
62
Hasbro
HAS
$12.6B
$1.07M 0.17%
24,000
-67,845
-74% -$3.67M
BAC icon
63
Bank of America
BAC
$435B
$1.07M 0.17%
83,069
+9,089
+12% +$141K
DVN icon
64
Devon Energy
DVN
$51.9B
$1.06M 0.17%
20,500
-4,060
-17% -$295K
FE icon
65
FirstEnergy
FE
$28.9B
$1.03M 0.17%
+27,509
New +$926K
AGN
66
DELISTED
Allergan Inc
AGN
$985K 0.16%
+11,700
New +$1.82M
FITB
67
Fifth Third Bancorp
FITB
$52B
$853K 0.14%
47,309
-33,531
-41% -$710K
ADI icon
68
Analog Devices
ADI
$181B
$829K 0.13%
18,400
-3,700
-17% -$196K
STJ
69
DELISTED
St Jude Medical
STJ
$803K 0.13%
17,600
+3,900
+28% +$253K
MRSH
70
Marsh
MRSH
$86.3B
$798K 0.13%
20,000
– –
CSX icon
71
CSX Corp
CSX
$98.6B
$631K 0.1%
81,672
-92,505
-53% -$901K
DD icon
72
DuPont de Nemours
DD
$18.6B
$537K 0.09%
6,595
-1,129
-15% -$144K
WBA
73
DELISTED
Walgreens Boots Alliance
WBA
$464K 0.08%
10,500
-13,933
-57% -$973K
ADSK icon
74
Autodesk
ADSK
$44.3B
$437K 0.07%
12,900
-13,300
-51% -$675K
PGI
75
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
$414K 0.07%
34,300
+3,400
+11% +$43.3K
1 2
3
4

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Cullinan Associates held 97 positions worth $615M, down 30% from $879M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Cullinan Associates withdrew a net $210M in Q2 2014, closing 17 positions and reducing 57 holdings. Its most notable exit was VF Corp, an estimated $7.28M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Cullinan Associates opened a new position in Raytheon Company worth $2.59M.

  • Cullinan Associates's largest Q2 2014 buy was Raytheon Company: 39,151 shares worth $2.59M.
  • Cullinan Associates added most to Xilinx Inc in Q2 2014, an estimated $1.66M increase.
  • Cullinan Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $43.4M.
  • Cullinan Associates fully exited VF Corp in Q2 2014, selling an estimated $7.28M.
  • Cullinan Associates's ten largest holdings make up 73% of its $615M portfolio in Q2 2014.
  • Cullinan Associates opened 9 new positions and closed 17 in Q2 2014.
  • Cullinan Associates's portfolio value fell 30% quarter-over-quarter to $615M.

Based on Cullinan Associates's 13F filing for Q2 2014, filed 15 Aug 2014.